Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients With Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerOncologist 2020 Nov 03;[EPub Ahead of Print], Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, JD Gillece, M Folkerts, L Reining, SK Highlander, K Robinson, S Padam, N Martinez, A Tang, D Schmolze, J Waisman, M Sedrak, PP Lee, J Mortimer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.